Remus Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 24, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Market Capitalization	14,449	10,163	-	-	-	-
Enterprise Value	14,421	10,212	-	-	-	-
Last Close Price	2452.35	1723.15	-	-	-	-
PE Ratio	48.34	47.19	-	-	-	-
PS Ratio	3.17	4.77	-	-	-	-
PB Ratio	14.38	9.74	-	-	-	-
P/TBV Ratio	16.94	13.11	-	-	-	-
P/FCF Ratio	-	342.57	-	-	-	-
P/OCF Ratio	-	282.11	-	-	-	-
EV/Sales Ratio	3.16	4.80	-	-	-	-
EV/EBITDA Ratio	33.99	35.41	-	-	-	-
EV/EBIT Ratio	34.83	36.52	-	-	-	-
EV/FCF Ratio	-	344.23	-	-	-	-
Debt / Equity Ratio	0.17	0.11	0.42	0.03	0.09	0.18
Debt / EBITDA Ratio	0.52	0.40	0.71	0.04	0.21	0.34
Debt / FCF Ratio	-	3.89	3.08	0.04	0.10	0.48
Asset Turnover	-	1.46	1.79	1.84	2.30	-
Inventory Turnover	-	7.62	22.88	8.96	14.50	-
Quick Ratio	1.12	0.96	0.97	0.44	0.58	0.97
Current Ratio	1.82	1.40	1.39	0.84	0.98	1.63
Return on Equity (ROE)	-	42.08%	66.14%	71.37%	40.49%	-
Return on Assets (ROA)	-	11.97%	26.40%	19.63%	8.89%	-
Return on Capital (ROIC)	-	24.45%	39.41%	52.34%	25.48%	-
Earnings Yield	2.07%	2.12%	-	-	-	-
FCF Yield	0.29%	-	-	-	-
Dividend Yield	0.08%	0.09%	-	-	-	-
Payout Ratio	0.00%	2.74%	-	-	-	-
Buyback Yield / Dilution	-8.32%	-38.79%	-2.10%	-	-	-
Total Shareholder Return	-8.24%	-38.70%	-2.10%	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.